RecruitingNot ApplicableNCT07129226

Musculoskeletal Cancers Remote Monitoring and Care


Sponsor

Case Comprehensive Cancer Center

Enrollment

60 participants

Start Date

Feb 11, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to evaluate how walking stability and the ability to perform daily activities change during cancer treatment, and whether a smartwatch can detect these changes. The goal is to develop proactive, personalized tools that automatically monitor treatment response and predict potential complications. To support future implementation, the study will assess the feasibility of wearing a smartwatch for at least 12 hours per day, using a mobile application, and completing weekly questionnaires among patients with primary osteosarcoma or metastatic bone disease.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a remote monitoring system — using a smartwatch — to track recovery and wellbeing in people with bone cancer or cancer that has spread to the bones of the legs or pelvis. **You may be eligible if...** - You have a primary bone sarcoma or cancer that has spread to the bones of the lower limbs or pelvis - You are being evaluated for surgery or radiation treatment - Your overall physical function is good (Karnofsky score of 70% or higher) **You may NOT be eligible if...** - You are under 18 years old - You cannot understand or sign the consent form - You do not have access to a smartphone (iOS or Android) - You have tattoos, skin conditions, or limb differences that prevent wearing a smartwatch on your wrist - You are unable to wear the watch for at least 12 hours a day on most days Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSmart Watch

Participants will be asked to wear the smartwatch daily, for at least 12 hours per day during the 12-week study period, with breaks to recharge the watch as needed.


Locations(1)

Case Comprehensive Cancer Center, Cleveland Clinic Foundation

Cleveland, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07129226


Related Trials